Healthy Clinical Trial
Official title:
Examining the Neural Bases of Early Visual and Auditory Processing and Emotion Recognition Deficits in Schizophrenia Using Magnetoencephalography
The purpose of this project is to examine potential mechanisms that may underlie early visual and auditory perception as well as visual and auditory affect perception deficits in schizophrenia and the possible connection between these processes. Given that affect perception largely involves visual and/or auditory information processing and likely relies on intact basic visual and/or auditory perceptual mechanisms, the investigators will examine affect perception deficits within the framework of the more basic visual and auditory processes. Specifically, the investigators will examine magnetophysiological correlates of vocal and visual affect discrimination, non-affective face discrimination and voice discrimination, and simple visual and auditory stimulus discrimination, using Magnetoencephalography (MEG), to identify neural mechanisms underlying perceptual deficits, as well as their contribution to affect perception deficits in schizophrenia.
Patients will be recruited from Shalvata mental health center and evaluated clinically in
Shalvata mental health center. The MEG scan will take place at Bar-Ilan University at the
Brain Research Center. Participants will get to and from the university with one of the
researchers. Patients from the closed ward will be taken from Shalvata mental health center
after receiving a signed letter from a relevant staff member allowing them to leave the
hospital for the purpose of the research. At the end of the experiment hospitalized patients
will be returned to the hospital and non-hospitalized ones to their preferred destination.
First stage (to take place in Shalvata): After the informed consent process a clinical
evaluation will be performed. The evaluation will be administered to all participants and
will include: demographic details and psychiatric history questionnaire, social functioning
scale, handedness questionnaire, four-factor index of social statues for socioeconomic
evaluation, Ischihara Color Blindness Test, Snellen wall chart for visual evaluation, TONI-3
test for intelligence evaluation, Hebrew version of the Manchester Short Assessment of
Quality of Life, Interpersonal Reaction Index for empathy evaluation, and SCID for DSM-IV.
In addition, the PANSS questionnaire will be administered to schizophrenic and
schizoaffective patients. Time estimation: 1-2 hours.
Second stage (to take place at Bar-Ilan University and if necessary to be divided into two
separate visits): Conducting a brain scan during a battery of tasks that will test neural
mechanisms underlying visual and auditory perceptual deficits, as well as their contribution
to affect perception deficits in schizophrenia at different levels of the visual and
auditory processing. This stage will begin with a preparation for the scan (10-20 minutes)
and then the following tasks will take place: Task 1. Gratings Perception task in which
participants have to detect the 5% vertical gratings. The aim of this task is to identify
the neural mechanisms underlying basic visual perceptual deficits in individuals with
schizophrenia by probing the M- and P-pathways using HSF and LSF in a neutral, semantically
meaningless, stimuli (~3 minutes); Task 2. Basic Color Processing Task - participants will
have to detect 5% of white backgrounds among 180 red, green and gray backgrounds. The aim of
this task is to asses neural mechanisms underlying basic visual perception by probing the M-
and P pathways using basic color stimuli (~3minutes); Task 3. Orientation Detection Task - a
task designed to identify another level of visual processing complexity, in which
participants are asked to detect a missing gap in a square, displaying on green, red or gray
background (~2 minutes); Task 4. Oddball Task in which participants have to detect
infrequent sounds and ignore frequent and novel sounds. The aim of this task is to identify
the basic neural mechanisms underlying auditory perception in individuals with schizophrenia
(~13 minutes); Task 5. High and low spatial frequency facial expressions perception task. In
this task participants have to identify the facial expression of the target stimuli out of
three possible expressions: neutral facial expression, happy facial expression and afraid
facial expression. The aim of this task is to identify the neural mechanisms underlying
neutral facial perception deficit as well as affect perception deficit in individuals with
schizophrenia by probing the M- and P-pathways using HSF and LSF facial stimuli (~25 minutes
including breaks). Task 6. Colored Face Recognition task - Face stimuli are the same as the
broad band stimuli from the previous task with one difference: faces are colored and
surrounded by red, green or gray colored backgrounds. Procedure is the same as in the
previous task (~25 minutes including breaks); Task 7. Processing of Affective Human Voices
task in which participants have to detect and identify the content of human sounds (~15
minutes). Time estimation of the second stage of the experiment is about two hours including
breaks. Total time estimation of both experimental stages: Four hours.
At the end of the experiment participants will be thanked and brought back to their
destination (hospitalized participants will be returned to Shalvata Hospital). Participants
will receive 200 NIS for transportation and time loss. Participants that will be screened
out during the evaluation stage will receive 50 NIS for transportation and time loss.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |